TFF2 and asthma: Contemporary studies have demonstrated that pulmonary disorders like asthma can stimulate airway epithelial cells to produce neurotrophic factors (e.g., NGF), which activate DRG via retrograde axonal transport, enhance the production of inflammatory neuropeptides such as substance P (SP), induce neurogenic inflammation, and exacerbate the pathological changes in the lung.